Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Context: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition. Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD. Design: The design was a randomized, double-blind, parallel-group, placebo-controlled, 24-wk study (the Intimate SM 1 study). Setting: The study was performed at private or institutional practices. Patients: The subjects studied were women, aged 26–70 yr, with HSDD after bilateral salpingo-oophorectomy who were receiving concomitant estrogen therapy. Placebo (n = 279) or testosterone 300 μg/d (n = 283) was administered. There were 19 patients who withdrew due to adverse events in the placebo group and 24 in the 300 μg/d testosterone group. Intervention: Testosterone (300 μg/d) or placebo patches were applied twice weekly. Main Outcome Measure(s): The primary end point was the change in the frequency of total satisfying sexual activity at 24 wk. Secondary end points included other sexual functioning end points and safety assessments. Results: At 24 wk, there was an increase from baseline in the frequency of total satisfying sexual activity of 2.10 episodes/4 wk in the testosterone group, which was significantly greater than the change of 0.98 episodes/4 wk in the placebo group (P = 0.0003). The testosterone group also experienced statistically significant improvements in sexual desire and a decrease in distress. The overall safety profile was similar in both treatment groups. Conclusion: In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another androgen (testosterone) also improves sexual function in surgically menopausal women (55,56).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [56]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954 · cited 1×
“01 300 g/d 271 7 [0, 14] 143 19 [9, 36] Androstenedione [50–250 ng/dl] Placebo 276 58 [32, 108] 157 52 [21, 87] 0.”
Self-citationSherwin, B. B., Gelfand, M. M., & Brender, W. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00004 · Cited by 547 · cited 1×
“5] Total testosterone [12–50 ng/dl] Placebo 279 17 [8, 28] 219 16 [7, 28] 0.”
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394
Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902317586001 · Cited by 289
HORMONAL DYNAMICS ASSOCIATED WITH THE MENOPAUSE
Judd, H. L. (1976) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-197612000-00005 · Cited by 158
LORENZO, E. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-5-556 · Cited by 131
Psychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
Nathorst-Böös, J., & von Schoultz, B. (1992) · Gynecologic and Obstetric Investigation · doi:10.1159/000292735 · Cited by 126
DEROGATIS, L., RUST, J., GOLOMBOK, S., BOUCHARD, C., NACHTIGALL, L., RODENBERG, C., KUZNICKI, J., & MCHORNEY, C. A. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490247183 · Cited by 121
Self-citationSexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis
ZUSSMAN, L., Zussman, S., Sunley, R., & Bjornson, E. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90730-4 · Cited by 103
Cited by
Items 101–200 of 472
Current Management Strategies of the Postmenopausal Patient with Sexual Health Problems
Goldstein, I. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00450.x · Cited by 72
Transcriptional Regulation of Natural Killer Cell Development and Functions
Wang, D., & Malarkannan, S. (2020) · Cancers · doi:10.3390/cancers12061591 · Cited by 76
Bloemers, J., van Rooij, K., Poels, S., Goldstein, I., Everaerd, W. T. A. M., Koppeschaar, H. P. F., Chivers, M. L., Gerritsen, J., van Ham, D., Olivier, B., et al. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02984.x · Cited by 65
Kingsberg, S. A., Simon, J. A., & Goldstein, I. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00961.x · Cited by 66
Self-citationTraish, A. M., Guay, A. T., Spark, R. F., & the Testosterone Therapy in Women Study Group (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00584.x · Cited by 64
Management of sexual dysfunction in breast cancer survivors: a systematic review
Seav, S. M., Dominick, S. A., Stepanyuk, B., Gorman, J. R., Chingos, D. T., Ehren, J. L., Krychman, M. L., & Su, H. I. (2015) · Women s Midlife Health · doi:10.1186/s40695-015-0009-4 · Cited by 59
Fooladi, E., Bell, R. J., Jane, F., Robinson, P. J., Kulkarni, J., & Davis, S. R. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12426 · Cited by 59
Self-citationComeglio, P., Cellai, I., Filippi, S., Corno, C., Corcetto, F., Morelli, A., Maneschi, E., Maseroli, E., Mannucci, E., Fambrini, M., et al. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.007 · Cited by 62
Guerrieri, G. M., Martinez, P. E., Klug, S. P., Haq, N., Vanderhoof, V. H., Koziol, D. E., Popat, V., Kalantaridou, S., Calis, K. A., Rubinow, D. R., et al. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000195 · Cited by 58
Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency
Kalantaridou, S., Vanderhoof, V. H., Calis, K. A., Corrigan, E. C., Troendle, J. F., & Nelson, L. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.040 · Cited by 57
Sexual Counseling in Elderly Couples
Bitzer, J., Platano, G., Tschudin, S., & Alder, J. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00926.x · Cited by 66
Testosterone therapy for sexual dysfunction in postmenopausal women
Hubayter, Z. R., & Simon, J. A. (2008) · Climacteric · doi:10.1080/13697130802162822 · Cited by 60
Self-citationRust, J. N., Derogatis, L. R., Rodenberg, C. A., Koochaki, P. E., Schmitt, S., & Golombok, S. E. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701592306 · Cited by 59
Self-citationMenopause and sexuality: key issues in premature menopause and beyond
Graziottin, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05680.x · Cited by 61
Self-Image and Sexuality Issues among Young Women with Breast Cancer: Practical Recommendations
Hungr, C., Varela, V. S., & Bober, S. L. (2017) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.17002200 · Cited by 72
Pérez-López, F. R., Phillips, N. A., Vieira‐Baptista, P., Cohen-Sacher, B., Fialho, S. C. A. V., & Stockdale, C. K. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1943346 · Cited by 53
Simon, J. A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2230 · Cited by 57
“The Investigation of Natural Testosterone in Menopausal Women Also Taking Estrogen in Surgically Menopausal Women (INTIMATE SM1 and SM2) enrolled 562 and 532 patients, respectively, with HSDD who received concomitant oral/transdermal estrogen.(54,55) The profiles of the Sexual Activity Log, PFSF, and PDS were used to…”
MethodSelf-citationGraziottin, A., Koochaki, P. E., Rodenberg, C. A., & Dennerstein, L. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01319.x · Cited by 52
Self-citationPharmacologically Induced Hypogonadism and Sexual Function in Healthy Young Women and Men
Schmidt, P. J., Steinberg, E. M., Negro, P. P., Haq, N., Gibson, C. J., & Rubinow, D. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.24 · Cited by 54
Sexual Function of Women with Chronic Illness and Cancer
Basson, R. J. (2010) · Women s Health · doi:10.2217/whe.10.23 · Cited by 61
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · Journal of Women s Health · doi:10.1089/jwh.2021.29037 · Cited by 57
Self-citationRole of testosterone in the treatment of hypoactive sexual desire disorder
Schwenkhagen, A., & Studd, J. W. W. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.02.011 · Cited by 65
Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus
Gordon, C., Wallace, D. J., Shinada, S., Kalunian, K. C., Forbess, L., Braunstein, G. D., & Weisman, M. H. (2007) · Rheumatology · doi:10.1093/rheumatology/kem342 · Cited by 50
Self-citationNappi, R. E., Ferdeghini, F., Sampaolo, P., Vaccaro, P., Leonardis, C. D., Albani, F., Salonia, A., & Polatti, F. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.04.014 · Cited by 50
Davis, S. R. (2024) · New England Journal of Medicine · doi:10.1056/nejmcp2313307 · Cited by 65
Self-citationSafarinejad, M. R., Hosseini, S. Y., Asgari, M. A., Dadkhah, F., & Taghva, A. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09208.x · Cited by 49
Sexual Desire and Arousal Disorders in Women
Laan, E., & Both, S. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000328806 · Cited by 49
Jayasena, C. N., Alkaabi, F., Liebers, C. S., Handley, T. J., Franks, S., & Dhillo, W. S. (2019) · Clinical Endocrinology · doi:10.1111/cen.13906 · Cited by 57
The effects of oestrogen on urogenital health
Lachowsky, M., & Nappi, R. E. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.012 · Cited by 48
“[9] Simon J, Braunstein G, Nachtigall L, et al.”
BackgroundMethodClayton, A. H., Dennerstein, L., Fisher, W. A., Kingsberg, S. A., Perelman, M. A., & Pyke, R. E. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01628.x · Cited by 47
The Genetics and Epidemiology of Female Sexual Dysfunction: A Review
Burri, A. V., Cherkas, L. M., & Spector, T. D. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01144.x · Cited by 204
“Testosterone/ Testosterone replacement therapy improves desire and arousal accompanied by an increase in sexual fantasies [88, 89 ].”
BackgroundSatisfying Sexual Events as Outcome Measures in Clinical Trial of Female Sexual Dysfunction
Kingsberg, S. A., & Althof, S. E. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02447.x · Cited by 48
Organ‐on‐a‐Chip Systems for Women's Health Applications
Nawroth, J. C., Rogal, J., Weiß, M., Brucker, S. Y., & Loskill, P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700550 · Cited by 47
Tuiten, A., van Rooij, K., Bloemers, J., Eisenegger, C., van Honk, J., Kessels, R., Kingsberg, S. A., Derogatis, L. R., de Leede, L., Gerritsen, J., et al. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.11.226 · Cited by 46
Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial
Shah, S., Bell, R. J., Savage, G., Goldstat, R., Papalia, M.-A., Kulkarni, J., Donath, S., & Davis, S. R. (2006) · Menopause · doi:10.1097/01.gme.0000227333.50867.4e · Cited by 44
Self-citationFemale Sexual Dysfunction: Pharmacologic and Therapeutic Interventions
Brubaker, L. W., & Guntupalli, S. R. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003941 · Cited by 56
The Incidence of Invasive Breast Cancer Among Women Prescribed Testosterone for Low Libido
Davis, S. R., Wolfe, R. S., Farrugia, H., Ferdinand, A. S., & Bell, R. J. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01289.x · Cited by 47
Self-citationThe Facial Width-to-Height Ratio Predicts Sex Drive, Sociosexuality, and Intended Infidelity
Arnocky, S. A., Carré, J. M., Bird, B. M., Moreau, B. J. P., Vaillancourt, T., Ortiz, T. L., & Marley, N. (2017) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1070-x · Cited by 48
Androgen deficiency: effects on body composition
Miller, K. K. (2008) · Pituitary · doi:10.1007/s11102-008-0121-7 · Cited by 49
Androgen treatment of postmenopausal women
Davis, S. R., & Worsley, R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.006 · Cited by 42
Self-citationTraish, A. M., & Gooren, L. J. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01962.x · Cited by 45
Bitzer, J., Giraldi, A. G. E., & Pfaus, J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02817.x · Cited by 43
Traish, A. M., Feeley, R. J., & Guay, A. T. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01121.x · Cited by 41
Androgens in postmenopausal women: a review
Shifren, J. L., & Davis, S. R. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000903 · Cited by 48
Self-citationQuality of Sexual Life and Menopause
Eden, K. J., & Wylie, K. R. (2009) · Women s Health · doi:10.2217/whe.09.24 · Cited by 48
“Most studies investigating short-term androgen therapy appear to demonstrate that use is well tolerated [47,48]; however, the possible side effects of androgen use include hirsutism, acne and other signs of virilization, polycythaemia, increased high-density lipoproteins, cardiovascular risk and possible endometrial h…”
BackgroundEstrogen and Androgen Hormone Therapy and Well-Being in Surgically Postmenopausal Women
Kotz, K. J., Alexander, J. L., & Dennerstein, L. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.898 · Cited by 43
“31 For a discussion of these studies the reader is referred to Alexander et al. 36 Two of these studies 22,25 looked at quality of life using the Psychological General Well-Being (PGWB) scale, as well as a validated sexual outcome instrument, although they did not include solely surgically…”
InfluentialEffects of testosterone and estrogen replacement on memory function
Möller, M. C., Bartfai, A., & Rådestad, A. F. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181dc2e40 · Cited by 41
“14 (11-25) NS (n = 44) (df = 43) (df = 43)”
Sexual Function Post-Breast Cancer
Streicher, L. F., & Simon, J. A. (2018) · Cancer treatment and research · doi:10.1007/978-3-319-70197-4_11 · Cited by 46
Self-citationUloko, M., Rahman, F., Puri, L. I., & Rubin, R. S. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00613-0 · Cited by 56
“[52] found that testosterone administration (via a patch) in combination with estrogen improved libido and the frequency.”
BackgroundTestosterone and Libido in Surgically and Naturally Menopausal Women
Alexander, J. L., Dennerstein, L., Burger, H., & Graziottin, A. (2006) · Women s Health · doi:10.2217/17455057.2.3.459 · Cited by 44
“• Braunstein and colleagues, 2005 [3] • Buster and colleagues, 2005 [2] • Simon and colleagues, 2005 [6] • Warnock and colleagues, 2005 [74] • Floter and colleagues, 2002 [75] • Shifren and colleagues, 2000 [1] • Sherwin & Gelfand, 1985 [76]”
BackgroundMethodInfluentialSexuality and breast cancer: prime time for young patients.
Pinto, A. C. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.05.23 · Cited by 71
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review
Gera, R., Tayeh, S., Chehade, H. E. H., & Mokbel, K. (2018) · Anticancer Research · doi:10.21873/anticanres.13028 · Cited by 38
Davis, S. R., Robinson, P. J., Moufarege, A., & Bell, R. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04301.x · Cited by 38
Self-citationPharmacokinetics of a Testosterone Gel in Healthy Postmenopausal Women
Singh, A. B., Lee, M. L., Sinha-Hikim, I., Kushnir, M., Meikle, W., Rockwood, A., Afework, S., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1640 · Cited by 38
“Well-controlled, randomized trials of the transdermal testosterone patch (18, 44, 47, 48) have demonstrated that raising total and free testosterone concentrations into a range that is at the upper end of the normal female range is associated with improvements in several domains of sexual function and well-being.”
BackgroundSurgical Management for Pelvic Organ Prolapse and Its Impact on Sexual Function
Thompson, J. C., & Rogers, R. G. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.02.002 · Cited by 37
Bremelanotide for Treatment of Female Hypoactive Sexual Desire
Edinoff, A. N., Sanders, N. M., Lewis, K. B., Apgar, T. L., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022) · Neurology International · doi:10.3390/neurolint14010006 · Cited by 46
Placebo Response in the Treatment of Women's Sexual Dysfunctions: A Review and Commentary
Bradford, A., & Meston, C. (2009) · Journal of Sex & Marital Therapy · doi:10.1080/00926230802716302 · Cited by 37
“We evaluated placebo group outcomes in seven studies that compared the efficacy of placebo to that of testosterone in the form of a transdermal patch or topical cream (Barton et al., 2007; Braunstein et al., 2005; Buster et al., 2005; Goldstadt, Briganti, Tran, Wolfe, & Davis, 2003; Shifren et al., 2000, 2006; Simon e…”
MethodChudakov, B., Ben-Zion, I., & Belmaker, R. H. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00405.x · Cited by 39
Androgens and female sexual function
Palacios, S. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.02.014 · Cited by 44
Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
Basaria, S. S., & Dobs, A. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0740 · Cited by 41
“In this multicenter study (52 centers in Australia, Canada, and the United States), the investigators recruited 562 surgically menopausal women (age 26–70 yr) on estrogen and randomized them to placebo (n 279) and 300- g testosterone patch (n 283) (61).”
BackgroundJiménez, M. V., & Solís, M. D. L. C. (2007) · Revista electrónica de terapia ocupacional Galicia, TOG · Cited by 37
Nijland, E. A., Davis, S. R., Laan, E. T. M., & Schultz, W. C. M. W. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00285.x · Cited by 38
Self-citationTestosterone Replacement Therapy in Naturally and Surgically Menopausal Women (CME)
Panzer, C., & Guay, A. T. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01128.x · Cited by 41
Management of hypoactive sexual desire disorder in women: current and emerging therapies
Nappi, R. E. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s7578 · Cited by 40
“54 A series of double-blind, randomized, placebo-controlled studies examined the efficacy and safety of a transdermal T patch (300 µ g) in postmenopausal women with HSDD. 55,56 Powered by TCPDF (www.tcpdf.org) Two multicenter trials evaluated 24 weeks of T patch treatment in over 1,000 surgically menopausal women with…”
InfluentialMiller, K. K., Biller, B. M. K., Schaub, A., Pulaski-Liebert, K., Bradwin, G., Rifai, N., & Klibanski, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0195 · Cited by 36
Testosterone Therapy for Female Sexual Dysfunction
Khera, M. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.53 · Cited by 38
Androgen therapy in women, beyond libido
Davis, S. R. (2013) · Climacteric · doi:10.3109/13697137.2013.801736 · Cited by 41
Self-citationMaseroli, E., Santangelo, A., Lara-Fontes, B., Quintana, G. R., Cionnaith, C. E. M., Casarrubea, M., Ricca, V., Maggi, M., Vignozzi, L., & Pfaus, J. G. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104606 · Cited by 35
Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction
Gama, C. R. B., Lasmar, R. B., Gama, G. F., Abreu, C. S., Nunes, C. P., Geller, M., Oliveira, L., & dos Santos, A. S. (2014) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s17853 · Cited by 44
Menopause and sexual desire: the role of testosterone
Nappi, R. E., Albani, F., Santamaria, V., Tonani, S., Martini, E., Terreno, E., Brambilla, E., & Polatti, F. (2010) · Menopause international · doi:10.1258/mi.2010.010041 · Cited by 35
Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women
Fooladi, E., Reuter, S. E., Bell, R. J., Robinson, P. J., & Davis, S. R. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000259 · Cited by 33
“3) [3-16]”
Self-citationKingsberg, S. A., & Simon, J. A. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.7865 · Cited by 44
“57,58 Generally, testosterone therapy significantly improved sexual activity and desire, while decreasing personal distress although with mostly mild androgenic adverse events (AEs).”
Self-citationDichtel, L. E., Carpenter, L. L., Nyer, M., Mischoulon, D., Kimball, A., Deckersbach, T., Dougherty, D. D., Schoenfeld, D., Fisher, L. B., Cusin, C., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19080844 · Cited by 36
Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder
Abdallah, R. T., & Simon, J. A. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901558 · Cited by 37
Self-citationBody Composition Characteristics Predict Sexual Functioning in Obese Women With or Without PCOS
Zueff, L. F. N., Lara, L. A. D. S., Vieira, C. S., Martins, W. P., & Ferriani, R. A. (2013) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2013.864369 · Cited by 32
“…and sexual desire in women has been supported by studies that have demonstrated that women receiving testosterone patch after undergoing hysterectomy with bilateral oophorectomy, in addition to estrogen, had increased sexual desire and reduced distress (Buster et al., 2005; Simon et al., 2005).”
ResultDerogatis, L. R., Graziottin, A., Bitzer, J., Schmitt, S., Koochaki, P. E., & Rodenberg, C. A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01058.x · Cited by 34
Self-citationKronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0265 · Cited by 53
A Model for the Management of Female Sexual Dysfunctions
Scalco, S. C. P., Troncon, J. K., Lopes, G. P., & Lara, L. A. D. S. (2017) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0037-1601435 · Cited by 36
Løbo, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00014-7 · Cited by 42
Symptoms: Menopause, Infertility, and Sexual Health
Barton, D. L., & Ganz, P. A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16366-6_9 · Cited by 35
Nonsteroidal Selective Androgen Receptor Modulators Enhance Female Sexual Motivation
Jones, A. J., Hwang, D., Duke, C. B., He, Y., Anjaiah, S., Miller, D. D., & Dalton, J. T. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168880 · Cited by 33
“, 2005) or 16 weeks of treatment (Simon et al., 2005).”
BackgroundPharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women
van Rooij, K., Bloemers, J., de Leede, L., Goldstein, I., Lentjes, E. G. W. M., Koppeschaar, H. P. F., Olivier, B., & Tuiten, A. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.008 · Cited by 32
“Chronic testosterone administration is utilized as the delivery option in the majority of studies regarding the influence of testosterone on women’s sexual behavior, including hormonal replacement therapy in naturally or surgically (bilateral oophorectomy) menopausal women (Shifren et al., 2000; Sherwin, 2002; Simon e…”
The role of testosterone in menopausal hormone treatment. What is the evidence?
Johansen, N., Hirschberg, A. L., & Moen, M. H. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13819 · Cited by 58
Transdermal menopausal hormone therapy: delivery through skin changes the rules
Buster, J. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003774098 · Cited by 31
“There are now seven randomized, blinded clinical trials involving the testosterone matrix patch on nearly 3000 HSDD afflicted postmenopausal women [26-32].”
BackgroundInfluentialReis, S. L. B., & Abdo, C. H. N. (2014) · Clinics · doi:10.6061/clinics/2014(04)11 · Cited by 35
“However, the most common adverse effects are acne and increased oiliness of the skin and hair (55), which were also reported in 3 of the studies shown in Table 1 (26,27,29).”
BackgroundMethodHypoactive Sexual Desire Disorder and Current Pharmacotherapeutic Options in Women
Palacios, S. (2011) · Women s Health · doi:10.2217/whe.10.81 · Cited by 38
“Nevertheless, more studies are needed, especially those analyzing physiological doses and those condcuted over a longer time period [48–53].”
BackgroundMethodInfluentialTreatments for Psychological Problems and Syndromes
Borg, C., de Jong, P. J., McKay, D., Abramowitz, J. S., & Storch, E. A. (2017) · Wiley eBooks · doi:10.1002/9781118877142 · Cited by 36
Bioidentical Hormones for Menopausal Therapy
Sites, C. K. (2008) · Women s Health · doi:10.2217/17455057.4.2.163 · Cited by 33
“This dosage appears to have minimal metabolic effects while increasing the number of satisfying sexual experiences per month in menopausal women [41].”
BackgroundMethodPharmacological Effects On Sexual Function
Carey, J. C. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2006.10.005 · Cited by 31
Stuursma, A., Lanjouw, L., Idema, D. L., de Bock, G. H., & Mourits, M. J. E. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.08.191 · Cited by 55
Shim, S., Park, K., Chung, Y., & Kim, J.-H. (2021) · Journal of Menopausal Medicine · doi:10.6118/jmm.20034 · Cited by 40
“However, current studies of systemic transdermal testosterone therapy, alone or in combination with ET, have not proven its effects on vaginal health [28,29].”
BackgroundReview: Testosterone therapy for reduced libido in women
Basson, R. J. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810379588 · Cited by 46
“Four involved surgically menopausal estrogenized women [Davis et al. 2006b; Braunstein et al. 2005; Buster et al. 2005; Simon et al. 2005].”
BackgroundResultSex, Drugs, and How to Deal with Criticism: The Case of Flibanserin
Bueter, A., & Jukola, S. (2020) · Boston studies in the philosophy of science · doi:10.1007/978-3-030-29179-2_20 · Cited by 31
National consensus on the management of patients in menopause
Вільєрс, Т. Д., Татарчук, Т. Ф., Авраменко, Н. В., Булавенко, О. В., Габаль, В. А., Burlaka, O., Ганжий, І. Ю., Геник, Н. І., Грищенко, О. В., Громова, А. М., et al. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.27.8-25 · Cited by 30
de Paula, F. J. F., Soares, J. M., Haidar, M. A., de Lima, G. R., & Baracat, E. C. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.06.005 · Cited by 29
Loss of Sexual Desire in the Postmenopausal Woman
Wylie, K. R., Daines, B., Jannini, E. A., Hallam-Jones, R., Boul, L., Wilson, L., Athanasiadis, L., Brewster, M., & Kristensen, E. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00419.x · Cited by 27
An update on the pharmacological management of female sexual dysfunction
Fooladi, E., & Davis, S. R. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.725046 · Cited by 27
“The TTP has been shown to be efficacious in both naturally [56] and surgically menopausal women [57] and for estrogen users [58] and non-users [59].”
BackgroundSelf-citationEvaluation of safety for flibanserin
Clayton, A. H., Brown, L., & Kim, N. N. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1707804 · Cited by 26
“ference between testosterone and placebo treatment groups with regard to AEs [58].”
BackgroundConsensus statement for non-hormonal-based treatments for menopausal symptoms
Woyka, J. (2017) · Post Reproductive Health · doi:10.1177/2053369117711646 · Cited by 31
Androgens, health and sexuality in women and men
Wylie, K. R., REES, M. C. P., Hackett, G. I., Anderson, R. A., Bouloux, P.-M. G., Cust, M., Goldmeier, D., Kell, P. D., TERRY, T. R., TRINICK, T. R., et al. (2010) · Human Fertility · doi:10.3109/14647273.2010.530966 · Cited by 30
“Hirsutism was reported overall in 7% of women receiving testosterone patches, versus 5% for controls, over a period of 24 weeks (Braunstein et al., 2005; Buster et al., 2005; Simon et al., 2005).”
BackgroundMethodInfluential
Metadata
- Authors
- Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., Rodenberg, C., Lucas, J., & Davis, S.
- Affiliations
- Women’s Health Research Center (J.S.), Laurel, Maryland 20707;
- Cedars-Sinai Medical Center (US)
- New York University (US)
- Rapid Medical Research (US)
- Katz, Kade, and Hewitt, Inc. (M.K.), Cincinnati, Ohio 45219;
- S. A. M. Clinical Research Center (S.M.), San Antonio, Texas 78229;
- Downtown Women's Health Care (US)
- Clinique RSF, Inc. (C.B.), Quebec, Canada G1S 2L6;
- St. Michael's Hospital (CA)
- Procter & Gamble (United States) (US)
- Jean Hailes (AU)
- Corresponding author
- Simon, James
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-09-01
- Volume
- 90
- Issue
- 9
- Pages
- 5226-5233
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041293595
- Semantic Scholar
- 26f1f458c86409345ab57bb45f0ed0c5705b02c2
- Cited by
- 475
- References
- 17
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 23 · 2020: 20 · 2019: 13 · 2018: 22 · 2017: 25 · 2016: 18 · 2015: 13 · 2014: 17 · 2013: 19 · 2012: 35
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone patch, hypoactive sexual desire disorder, surgical menopause, sexual desire, sexual activity, sexual dysfunction, salpingo-oophorectomy, estrogen therapy, testosterone replacement therapy, treatment safety
- MeSH terms
- Administration, Cutaneous, Androgens, Double-Blind Method, Female, Humans, Libido, Menopause, Premature, Sexual Behavior, Gynecologic Surgical Procedures, Testosterone, Treatment Outcome, Sexual Dysfunctions, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.